跳至主要内容
临床试验/NL-OMON56247
NL-OMON56247尚未招募不适用

External validation of the beta-lactam target non-attainment (BATMAN) risk score in adult ICU patients: a diagnostic multivariate predictive risk model - BATMA

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 148 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • All patients admitted to the adult general ICU wards and given standard of care
  • intravenous therapy of the target antibiotic are screened for eligibility. In
  • order to be eligible to participate in this study, a subject must meet all of
  • the following criteria:
  • Written informed consent has been obtained from the patient or their legally
  • authorised representative
  • Age >=18 years
  • Treated with one of the following beta-lactam antibiotics at the ICU with
  • intermitted dosage.
  • o Amoxicillin
  • o Amoxicillin with clavulanic acid
  • o Cefotaxime
  • o Ceftazidime
  • o Cefuroxime
  • o Flucloxacillin
  • o Meropenem
  • o Piperacillin with tazobactam
  • Eligible blood material within 36 hours after start of beta-lactam antibiotic
  • to determine target attainment (100%*T > MICECOFF).
  • Suitable intravenous/intra-arterial access to facilitate sample collection

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Written consent has not been obtained
  • <18 years
  • Pregnancy
  • Beta-lactam antibiotic cessation before blood sample collection
  • Receiving beta-lactam antibiotic only as prophylaxis
  • No intravenous/intra-arterial access
  • Patients with renal replacement therapy
  • Patients with burn injury

研究者

相似试验